nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrosine—TH—vagus nerve—esophageal cancer	0.373	0.849	CbGeAlD
Metyrosine—TH—Alpha-synuclein signaling—UCHL1—esophageal cancer	0.0524	0.113	CbGpPWpGaD
Metyrosine—TH—Alpha-synuclein signaling—FKBP1A—esophageal cancer	0.0498	0.108	CbGpPWpGaD
Metyrosine—TH—Parkinsons Disease Pathway—UCHL1—esophageal cancer	0.0445	0.0961	CbGpPWpGaD
Metyrosine—TH—p38 signaling mediated by MAPKAP kinases—SFN—esophageal cancer	0.0435	0.0939	CbGpPWpGaD
Metyrosine—TH—digestive system—esophageal cancer	0.0423	0.0963	CbGeAlD
Metyrosine—TH—Dopaminergic Neurogenesis—SOX2—esophageal cancer	0.0338	0.0729	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—CRTC1—esophageal cancer	0.0299	0.0645	CbGpPWpGaD
Metyrosine—TH—lymph node—esophageal cancer	0.0242	0.055	CbGeAlD
Metyrosine—Hypervigilance—Methotrexate—esophageal cancer	0.0158	0.278	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.0157	0.034	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—CRTC1—esophageal cancer	0.0128	0.0277	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.0101	0.0219	CbGpPWpGaD
Metyrosine—Ibuprofen—BCL2—esophageal cancer	0.00972	0.24	CrCbGaD
Metyrosine—TH—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00935	0.0202	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00903	0.0195	CbGpPWpGaD
Metyrosine—Acetaminophen—CYP2A6—esophageal cancer	0.00874	0.216	CrCbGaD
Metyrosine—TH—ATF-2 transcription factor network—NOS2—esophageal cancer	0.00835	0.018	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—HIF1A—esophageal cancer	0.00801	0.0173	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—RB1—esophageal cancer	0.00747	0.0161	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—SST—esophageal cancer	0.00702	0.0152	CbGpPWpGaD
Metyrosine—Acetaminophen—PTGS1—esophageal cancer	0.00669	0.166	CrCbGaD
Metyrosine—TH—ATF-2 transcription factor network—BCL2—esophageal cancer	0.00646	0.014	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—PSME1—esophageal cancer	0.00625	0.0135	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—PSME2—esophageal cancer	0.00625	0.0135	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—CDKN2A—esophageal cancer	0.00573	0.0124	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—GHRL—esophageal cancer	0.00559	0.0121	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—CCND1—esophageal cancer	0.00555	0.012	CbGpPWpGaD
Metyrosine—Speech impairment NOS—Methotrexate—esophageal cancer	0.00523	0.0917	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—EP300—esophageal cancer	0.00511	0.011	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—CCND1—esophageal cancer	0.00484	0.0105	CbGpPWpGaD
Metyrosine—Trismus—Capecitabine—esophageal cancer	0.00459	0.0806	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—EP300—esophageal cancer	0.00445	0.00962	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.00422	0.00911	CbGpPWpGaD
Metyrosine—Ibuprofen—PTGS1—esophageal cancer	0.00398	0.0984	CrCbGaD
Metyrosine—TH—AP-1 transcription factor network—MYC—esophageal cancer	0.00388	0.00838	CbGpPWpGaD
Metyrosine—Acetaminophen—PTGS2—esophageal cancer	0.00382	0.0947	CrCbGaD
Metyrosine—TH—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.00345	0.00744	CbGpPWpGaD
Metyrosine—Acetaminophen—ABCB1—esophageal cancer	0.00325	0.0805	CrCbGaD
Metyrosine—TH—AP-1 transcription factor network—TP53—esophageal cancer	0.00319	0.00688	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—NOS2—esophageal cancer	0.00313	0.00676	CbGpPWpGaD
Metyrosine—TH—Metabolism—SLC52A3—esophageal cancer	0.00292	0.00632	CbGpPWpGaD
Metyrosine—TH—Metabolism—BLVRB—esophageal cancer	0.00292	0.00632	CbGpPWpGaD
Metyrosine—TH—Metabolism—CA1—esophageal cancer	0.00249	0.00537	CbGpPWpGaD
Metyrosine—TH—Metabolism—SLC10A2—esophageal cancer	0.00249	0.00537	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.00235	0.00507	CbGpPWpGaD
Metyrosine—TH—Metabolism—CA2—esophageal cancer	0.00227	0.00491	CbGpPWpGaD
Metyrosine—Ibuprofen—PTGS2—esophageal cancer	0.00227	0.0563	CrCbGaD
Metyrosine—TH—Metabolism—ADH7—esophageal cancer	0.00211	0.00457	CbGpPWpGaD
Metyrosine—TH—Metabolism—PLCE1—esophageal cancer	0.00211	0.00457	CbGpPWpGaD
Metyrosine—Ibuprofen—ABCB1—esophageal cancer	0.00193	0.0478	CrCbGaD
Metyrosine—TH—Circadian rythm related genes—EP300—esophageal cancer	0.00192	0.00414	CbGpPWpGaD
Metyrosine—TH—Metabolism—ADH1B—esophageal cancer	0.00185	0.004	CbGpPWpGaD
Metyrosine—TH—Metabolism—TYMP—esophageal cancer	0.00177	0.00383	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP26A1—esophageal cancer	0.00172	0.00372	CbGpPWpGaD
Metyrosine—TH—Metabolism—ALOX15—esophageal cancer	0.00168	0.00363	CbGpPWpGaD
Metyrosine—Nasal congestion—Cisplatin—esophageal cancer	0.00166	0.0291	CcSEcCtD
Metyrosine—TH—Metabolism—GSTO1—esophageal cancer	0.0016	0.00346	CbGpPWpGaD
Metyrosine—TH—Metabolism—TPI1—esophageal cancer	0.0016	0.00346	CbGpPWpGaD
Metyrosine—TH—Metabolism—ALDOB—esophageal cancer	0.00154	0.00332	CbGpPWpGaD
Metyrosine—TH—Metabolism—GAPDH—esophageal cancer	0.00148	0.00319	CbGpPWpGaD
Metyrosine—TH—Metabolism—CRABP1—esophageal cancer	0.00147	0.00317	CbGpPWpGaD
Metyrosine—TH—Metabolism—GNG7—esophageal cancer	0.00139	0.00301	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—TP53—esophageal cancer	0.00137	0.00296	CbGpPWpGaD
Metyrosine—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00136	0.0238	CcSEcCtD
Metyrosine—Speech disorder—Methotrexate—esophageal cancer	0.00133	0.0233	CcSEcCtD
Metyrosine—TH—Metabolism—ALDH2—esophageal cancer	0.00131	0.00282	CbGpPWpGaD
Metyrosine—Swelling—Capecitabine—esophageal cancer	0.00126	0.0221	CcSEcCtD
Metyrosine—TH—Metabolism—GSTT1—esophageal cancer	0.00124	0.00268	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP2A6—esophageal cancer	0.00123	0.00265	CbGpPWpGaD
Metyrosine—TH—Metabolism—ENO1—esophageal cancer	0.00116	0.00251	CbGpPWpGaD
Metyrosine—TH—Metabolism—PTGS1—esophageal cancer	0.00116	0.00251	CbGpPWpGaD
Metyrosine—TH—Metabolism—PSME2—esophageal cancer	0.00115	0.00248	CbGpPWpGaD
Metyrosine—TH—Metabolism—PSME1—esophageal cancer	0.00115	0.00248	CbGpPWpGaD
Metyrosine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.001	0.0176	CcSEcCtD
Metyrosine—TH—Metabolism—CYP1B1—esophageal cancer	0.00099	0.00214	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP19A1—esophageal cancer	0.000931	0.00201	CbGpPWpGaD
Metyrosine—Dysuria—Capecitabine—esophageal cancer	0.000899	0.0158	CcSEcCtD
Metyrosine—Tremor—Cisplatin—esophageal cancer	0.000852	0.0149	CcSEcCtD
Metyrosine—TH—Metabolism—HMOX1—esophageal cancer	0.000849	0.00183	CbGpPWpGaD
Metyrosine—Anaemia—Cisplatin—esophageal cancer	0.00084	0.0147	CcSEcCtD
Metyrosine—Haematuria—Capecitabine—esophageal cancer	0.000818	0.0143	CcSEcCtD
Metyrosine—TH—Metabolism—ABCB1—esophageal cancer	0.000815	0.00176	CbGpPWpGaD
Metyrosine—Anxiety—Cisplatin—esophageal cancer	0.000771	0.0135	CcSEcCtD
Metyrosine—Oedema peripheral—Capecitabine—esophageal cancer	0.000758	0.0133	CcSEcCtD
Metyrosine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000726	0.0127	CcSEcCtD
Metyrosine—Eosinophilia—Methotrexate—esophageal cancer	0.000709	0.0124	CcSEcCtD
Metyrosine—Dysuria—Methotrexate—esophageal cancer	0.000669	0.0117	CcSEcCtD
Metyrosine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000659	0.0116	CcSEcCtD
Metyrosine—Tremor—Capecitabine—esophageal cancer	0.000628	0.011	CcSEcCtD
Metyrosine—Anaemia—Capecitabine—esophageal cancer	0.000619	0.0109	CcSEcCtD
Metyrosine—Feeling abnormal—Cisplatin—esophageal cancer	0.000611	0.0107	CcSEcCtD
Metyrosine—Haematuria—Methotrexate—esophageal cancer	0.000609	0.0107	CcSEcCtD
Metyrosine—Anxiety—Capecitabine—esophageal cancer	0.000569	0.00997	CcSEcCtD
Metyrosine—Dry mouth—Capecitabine—esophageal cancer	0.000558	0.00979	CcSEcCtD
Metyrosine—Confusional state—Capecitabine—esophageal cancer	0.000551	0.00967	CcSEcCtD
Metyrosine—Hypersensitivity—Cisplatin—esophageal cancer	0.000547	0.00959	CcSEcCtD
Metyrosine—TH—Metabolism—CREBBP—esophageal cancer	0.000545	0.00118	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000535	0.00939	CcSEcCtD
Metyrosine—Asthenia—Cisplatin—esophageal cancer	0.000532	0.00934	CcSEcCtD
Metyrosine—Diarrhoea—Cisplatin—esophageal cancer	0.000508	0.00891	CcSEcCtD
Metyrosine—Insomnia—Capecitabine—esophageal cancer	0.000495	0.00868	CcSEcCtD
Metyrosine—TH—Metabolism—NOS3—esophageal cancer	0.000488	0.00105	CbGpPWpGaD
Metyrosine—Vomiting—Cisplatin—esophageal cancer	0.000472	0.00828	CcSEcCtD
Metyrosine—Fatigue—Capecitabine—esophageal cancer	0.000471	0.00827	CcSEcCtD
Metyrosine—Anaemia—Methotrexate—esophageal cancer	0.000461	0.00809	CcSEcCtD
Metyrosine—Feeling abnormal—Capecitabine—esophageal cancer	0.000451	0.00791	CcSEcCtD
Metyrosine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000447	0.00785	CcSEcCtD
Metyrosine—TH—Metabolism—PTGS2—esophageal cancer	0.000446	0.000964	CbGpPWpGaD
Metyrosine—Nausea—Cisplatin—esophageal cancer	0.000441	0.00773	CcSEcCtD
Metyrosine—Urticaria—Capecitabine—esophageal cancer	0.000434	0.00762	CcSEcCtD
Metyrosine—Abdominal pain—Capecitabine—esophageal cancer	0.000432	0.00758	CcSEcCtD
Metyrosine—Confusional state—Methotrexate—esophageal cancer	0.00041	0.0072	CcSEcCtD
Metyrosine—Hypersensitivity—Capecitabine—esophageal cancer	0.000403	0.00707	CcSEcCtD
Metyrosine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000399	0.00699	CcSEcCtD
Metyrosine—Asthenia—Capecitabine—esophageal cancer	0.000392	0.00688	CcSEcCtD
Metyrosine—Diarrhoea—Capecitabine—esophageal cancer	0.000374	0.00656	CcSEcCtD
Metyrosine—TH—Metabolism—EP300—esophageal cancer	0.000371	0.000801	CbGpPWpGaD
Metyrosine—Insomnia—Methotrexate—esophageal cancer	0.000368	0.00646	CcSEcCtD
Metyrosine—Fatigue—Methotrexate—esophageal cancer	0.000351	0.00616	CcSEcCtD
Metyrosine—Vomiting—Capecitabine—esophageal cancer	0.000348	0.0061	CcSEcCtD
Metyrosine—Headache—Capecitabine—esophageal cancer	0.000343	0.00601	CcSEcCtD
Metyrosine—Feeling abnormal—Methotrexate—esophageal cancer	0.000335	0.00589	CcSEcCtD
Metyrosine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000333	0.00584	CcSEcCtD
Metyrosine—Nausea—Capecitabine—esophageal cancer	0.000325	0.0057	CcSEcCtD
Metyrosine—Urticaria—Methotrexate—esophageal cancer	0.000323	0.00567	CcSEcCtD
Metyrosine—Abdominal pain—Methotrexate—esophageal cancer	0.000322	0.00565	CcSEcCtD
Metyrosine—Hypersensitivity—Methotrexate—esophageal cancer	0.0003	0.00526	CcSEcCtD
Metyrosine—Asthenia—Methotrexate—esophageal cancer	0.000292	0.00512	CcSEcCtD
Metyrosine—Diarrhoea—Methotrexate—esophageal cancer	0.000279	0.00489	CcSEcCtD
Metyrosine—TH—Metabolism—PIK3CA—esophageal cancer	0.000275	0.000593	CbGpPWpGaD
Metyrosine—Vomiting—Methotrexate—esophageal cancer	0.000259	0.00454	CcSEcCtD
Metyrosine—Headache—Methotrexate—esophageal cancer	0.000255	0.00447	CcSEcCtD
Metyrosine—Nausea—Methotrexate—esophageal cancer	0.000242	0.00424	CcSEcCtD
